Copyright
©2013 Baishideng Publishing Group Co.
World J Gastroenterol. May 14, 2013; 19(18): 2781-2792
Published online May 14, 2013. doi: 10.3748/wjg.v19.i18.2781
Published online May 14, 2013. doi: 10.3748/wjg.v19.i18.2781
Figure 6 Combination of mitogen-activated protein kinase activator with WD40 repeats binding protein and mitogen-activated protein kinase activator with WD40 repeats inhibited the transforming growth factor-β pathway.
A: The level of p-Smad3 was lowest in the mitogen-activated protein kinase activator (MAWD) with WD40 repeats binding protein (MAWBP)/D cotransfected group and highest in the vector group. p-Smad2 was also lower in the MAWBP/D group; B, C: Nuclear translocation capability of p-Smad3 in cotransfected cells was weakest that means the activity of transforming growth factor (TGF)-β pathway in co-expression group was inhibited. DAPI: 4’,6-diamidino-2-phenylindole.
- Citation: Li DM, Zhang J, Li WM, Cui JT, Pan YM, Liu SQ, Xing R, Lu YY. MAWBP and MAWD inhibit proliferation and invasion in gastric cancer. World J Gastroenterol 2013; 19(18): 2781-2792
- URL: https://www.wjgnet.com/1007-9327/full/v19/i18/2781.htm
- DOI: https://dx.doi.org/10.3748/wjg.v19.i18.2781